(NASDAQ:INFI), its shares were trading at $1.08 a retreat of $-0.03, on the trading floor. Sold All: 30 Reduced: 73 Increased: 64 New Position: 60. The average true range of the stock is observed at 1.47 and the relative strength index …
Infinity Pharmaceuticals Inc. (INFI) traded on unusually high volume on Aug. 11, as the stock lost 2.56% to close at $1.14. On the day, Infinity Pharmaceuticals Inc. saw 627,359 shares trade hands on 1,584 trades. Considering that the stock
July 27, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), today announced that it has amended ... before the maturity date in cash or in shares of Infinity common stock, at the election of Takeda. The share payment …
Infinity Pharmaceuticals, Inc. INFI reported a loss of 34 cents per share in second ... Zacks Rank & Key Pick Infinity currently holds a Zacks Rank #3 (Hold). A better-ranked stock in the healthcare sector is Gilead Sciences. Inc. GILD …
The press release issued earlier today details our results and is available on our website at infi.com. Please note that …
Infinity Pharmaceuticals is having a very strong start to the trading session today. When the opening bell rang, the stock was already trading slightly in the green. From there, the stock has made a mad dash toward the top. Below, we'll talk …
Admittedly, INFI stock is extremely speculative. Nevertheless, a little bit of positive news could go a long way for …
Another name among hard-hit pharma stocks is Infinity Pharmaceuticals Inc. (NASDAQ:INFI). Already flirting with penny stock prices late last year, INFI stock made it official a few months ago on June 14. After the company disclosed that …
They now have a USD 22 price target on the stock. 09/03/2014 – Infinity Pharmaceuticals, Inc. had its “” rating reiterated …